After the entry into force of new US sanctions in the Russian Federation, American Medtronic’s CGM (continuous glucose monitoring) systems for diabetics became unusable. He writes about it”Kommersant“
The supply disruptions are attributed to the inclusion of components for glucose monitoring systems in the list of dual-use products. It is stated that such systems from the American Abbott are offered on the Russian market, but they are not intended for use by children with diabetes under four years of age. At the same time, according to doctors, Chinese analogues of these systems do not yet meet the requirements for effectiveness.
The CGM system continuously measures glucose levels in the interstitial fluid under the skin using a sensor. Data from the sensor is sent to the smartphone, allowing you to monitor sugar levels in real time.
Before reportedshowed that increased folic acid intake reduced the risk of death from diabetes.
Previously in Russian pharmacies stated about the lack of a popular antidepressant.